1. Home
  2. Labeler Index
  3. Physicians Total Care, Inc.
  4. 54868-6440
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 54868-6440 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Package Label – 320 mg/12.5 mg Rx Only NDC 0781-5951-92 Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/12.5 mg per tablet 90 tablets - 6440

Package Label – 320 mg/12.5 mg Rx Only NDC 0781-5951-92 Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/12.5 mg per tablet 90 tablets - 6440

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valsartan hct 1

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valsartan hct 1

This text is describing blood pressure readings with a target SBP of less than 140 mmHg. It also mentions the drugs "Valaran" and "Fydrochiorotazide" but it is unclear in what context they are being used. It includes a graph with baseline SBP readings ranging from 140 to 180 mmHg.*

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valsartan hct 2

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valsartan hct 2

This appears to be a blood pressure chart comparing the baseline diastolic blood pressure (DBP) to the DBP after treatment with different medications including valsartan and hydrochlorothiazide. The chart also shows a target DBP of less than 90 mmHg.*

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valsartan hct 3

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valsartan hct 3

This is a table showing the results of a clinical study for a medication called Valsartan and Hydrochlorothiazide. The medication was given to participants in different dosages, and the effect on systolic blood pressure (SBP) was measured over time. The left column shows the baseline SBP readings of the participants, while the top row shows the different dosage levels given. Any additional information or description is not available from the given text.*

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valsartan hct 4

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valsartan hct 4

This is a graph representing the baseline diastolic blood pressure (DBP) in mmHg of patients taking Valsartan and Hydrochlorothiazide at different doses. The graph ranges from 0 to 110 on the x-axis and 0 to 100 on the y-axis, with different labels for each axis point. There is also a placebo group, represented by the label "Sol XXX Placebo."*

valsartan chemical structure - valsartan hct 5

valsartan chemical structure - valsartan hct 5

Hydrochlorothiazide chemical structure - valsartan hct 6

Hydrochlorothiazide chemical structure - valsartan hct 6

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.